Bausch & Lomb BLCO
NYSE BLCO
$17.09 +0.14 (+0.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Asset Writedowns and Impairment (2021 - 2026)

Updated

Bausch & Lomb (BLCO) recorded Asset Writedowns and Impairment of $9 million in Q2 2026.

Analysis

Bausch & Lomb (BLCO) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends

For FY2024, Bausch & Lomb reported Asset Writedowns and Impairment of $5 million.

  • Annual Asset Writedowns and Impairment has a four-year compound annual growth rate of 49.5% (FY2020 to FY2024).
  • Across earlier years, Asset Writedowns and Impairment came in at $1 million in FY2022 (-91.7%), $12 million in FY2021 and $1 million in FY2020.
  • The Q2 2026 figure is the lowest quarterly Asset Writedowns and Impairment since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Bausch & Lomb 6.10 Bn 4.84 Bn 867.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.00 Mn
Jun 30, 2024 5.00 Mn
Sep 30, 2022 1.00 Mn
Dec 31, 2021 1.00 Mn
Sep 30, 2021 8.00 Mn
Jun 30, 2021 2.00 Mn
Mar 31, 2021 1.00 Mn
API Access

Bausch & Lomb Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BLCO&period=max&api_key=YOUR_API_KEY